GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Aetna Inc. (AET) [hlAlert]

Rating:
Overweight
AET
up 110.58 %

Aetna Inc. (AET) rated Overweight by JP Morgan

Posted on: Friday,  Dec 7, 2012  8:25 AM ET by JP Morgan

JP Morgan rated Overweight Aetna Inc. (NYSE: AET) on 12/07/2012. Previously JP Morgan rated Buy Aetna Inc. (NYSE: AET) on 11/26/2007.,
when the stock price was $55.93. Since then, Aetna Inc. has gained 110.58% as of 09/18/2015's recent price of $117.78.
If you would have followed the previous JP Morgan's recommendation on AET, you would have gained 110.58% of your investment in 2853 days.

Aetna Inc. is one of the nation's largest health benefits companies and one of the nation's largest insurance and financial services organizations. Aetna provides these benefits to employer and plan sponsor customers in all 50 states, ranging from large multisite national accounts to middle-market and small-employer groups. Its products include the full range of health insurance, including dental and pharmacy benefits, from HMO and POS to PPO and indemnity, as well as group insurance products such as life, disability and long-term care insurance.

JPMorgan is a leading financial services firm with one of the largest client franchises in the world. We partner with our clients to offer the most complete and innovative solutions in the industry to help them achieve their goals. For more than 200 years, we have taken a long-term approach to our clients and to the way we conduct business. Our firm has grown considerably in scale and scope, but our commitment to our core principle of doing "only first-class business... in a first-class way" has never been stronger.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
12/7/2012 8:25 AM Buy
None
44.40
as of 12/31/2012
1 Week down  -0.40 %
1 Month up  7.22 %
3 Months up  16.94 %
1 YTD up  9.76 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
11/26/2007 9:25 AM Buy
None
55.93

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy